Susanne Schnabl

639 total citations
15 papers, 461 citations indexed

About

Susanne Schnabl is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Susanne Schnabl has authored 15 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 10 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Susanne Schnabl's work include Chronic Lymphocytic Leukemia Research (10 papers), Glycosylation and Glycoproteins Research (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). Susanne Schnabl is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Glycosylation and Glycoproteins Research (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). Susanne Schnabl collaborates with scholars based in Austria, United States and Slovakia. Susanne Schnabl's co-authors include Medhat Shehata, Rainer Hubmann, Martin Hilgarth, Maite P. Quiroga, Michael J. Keating, Ulrich Jäger, Antonina V. Kurtova, Rong Chen, Mariela Sivina and Neil E. Kay and has published in prestigious journals such as Blood, British Journal of Haematology and Frontiers in Pharmacology.

In The Last Decade

Susanne Schnabl

14 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susanne Schnabl Austria 8 266 243 123 104 99 15 461
Valérie Camara‐Clayette France 13 139 0.5× 189 0.8× 92 0.7× 153 1.5× 81 0.8× 24 453
Elisa Mandato Italy 8 134 0.5× 176 0.7× 108 0.9× 165 1.6× 136 1.4× 13 390
Antonella Contri Italy 6 309 1.2× 295 1.2× 169 1.4× 93 0.9× 158 1.6× 6 582
Laura Quotti Tubi Italy 10 98 0.4× 275 1.1× 52 0.4× 114 1.1× 62 0.6× 21 411
Susana Lisboa Portugal 12 84 0.3× 241 1.0× 48 0.4× 93 0.9× 110 1.1× 25 433
Kerstin Maria Kampa-Schittenhelm Germany 12 80 0.3× 283 1.2× 90 0.7× 171 1.6× 34 0.3× 30 516
Mikara Robati Australia 9 59 0.2× 357 1.5× 162 1.3× 164 1.6× 52 0.5× 11 511
Christelle Vincent‐Fabert France 15 93 0.3× 235 1.0× 394 3.2× 93 0.9× 78 0.8× 27 609
Jean‐Loup Huret France 6 92 0.3× 165 0.7× 40 0.3× 49 0.5× 36 0.4× 13 348

Countries citing papers authored by Susanne Schnabl

Since Specialization
Citations

This map shows the geographic impact of Susanne Schnabl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne Schnabl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne Schnabl more than expected).

Fields of papers citing papers by Susanne Schnabl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanne Schnabl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne Schnabl. The network helps show where Susanne Schnabl may publish in the future.

Co-authorship network of co-authors of Susanne Schnabl

This figure shows the co-authorship network connecting the top 25 collaborators of Susanne Schnabl. A scholar is included among the top collaborators of Susanne Schnabl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanne Schnabl. Susanne Schnabl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Hubmann, Rainer, Susanne Schnabl, Christian Schmidl, et al.. (2020). Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL. Cells. 9(6). 1484–1484. 9 indexed citations
2.
Vašíček, Jaromír, Andrej Baláži, Lucia Olexíková, et al.. (2019). Combined approach for characterization and quality assessment of rabbit bone marrow-derived mesenchymal stem cells intended for gene banking. New Biotechnology. 54. 1–12. 11 indexed citations
3.
Vašíček, Jaromír, Medhat Shehata, Susanne Schnabl, et al.. (2018). Critical assessment of the efficiency of CD34 and CD133 antibodies for enrichment of rabbit hematopoietic stem cells. Biotechnology Progress. 34(5). 1278–1289. 7 indexed citations
4.
Hubmann, Rainer, Wolfgang Sieghart, Susanne Schnabl, et al.. (2017). Gliotoxin Targets Nuclear NOTCH2 in Human Solid Tumor Derived Cell Lines In Vitro and Inhibits Melanoma Growth in Xenograft Mouse Model. Frontiers in Pharmacology. 8. 319–319. 25 indexed citations
5.
Hubmann, Rainer, Martin Hilgarth, Susanne Schnabl, et al.. (2012). Gliotoxin is a potent NOTCH2 transactivation inhibitor and efficiently induces apoptosis in chronic lymphocytic leukaemia (CLL) cells. British Journal of Haematology. 160(5). 618–629. 31 indexed citations
6.
7.
Hubmann, Rainer, Martin Hilgarth, Susanne Schnabl, et al.. (2011). Inhibition of NOTCH Activity by GLIOTOXIN Induces Apoptosis in CLL Cells and Overcomes the Supportive Effect of Primary Bone Marrow Stromal Cells. Blood. 118(21). 4609–4609. 2 indexed citations
8.
9.
Shehata, Medhat, Rainer Hubmann, Martin Hilgarth, et al.. (2010). Partial Characterization and In Vitro Expansion of Putative CLL Precursor/Stem Cells Which Are Dependent on Bone Marrow Microenvironment for Survival. Blood. 116(21). 2433–2433. 1 indexed citations
10.
Hubmann, Rainer, Markus Düchler, Susanne Schnabl, et al.. (2009). NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells. British Journal of Haematology. 148(6). 868–878. 24 indexed citations
11.
Shehata, Medhat, Susanne Schnabl, Stefanie Tauber, et al.. (2009). Lumiliximab Triggers Apoptosis Mechanisms in CLL Cells through the Inhibition of PI3-K/Akt Pathway.. Blood. 114(22). 2371–2371.
12.
13.
Shehata, Medhat, Susanne Schnabl, Dita Demirtas, et al.. (2008). Effective Targeting of the PI3-K Pathway in CLL with NVP-BEZ235, a Novel Orally Available Dual PI3K/mTOR Inhibitor. Blood. 112(11). 3166–3166. 2 indexed citations
14.
Hubmann, Rainer, Markus Duechler, Martin Hilgarth, et al.. (2006). Regulation of NOTCH2 Signaling in B-CLL: Involvement of PKC-δ.. Blood. 108(11). 1440–1440. 1 indexed citations
15.
Shehata, Medhat, Susanne Schnabl, Dita Demirtas, et al.. (2005). Interaction between B-CLL Cells and Lymphoid Microenvironment Leads to Activation of PI3-K/Akt Pathway and Inhibition of Apoptosis.. Blood. 106(11). 2102–2102. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valérie Camara‐Clayette Breakdown of academic impact, for papers by Elisa Mandato Breakdown of academic impact, for papers by Antonella Contri Breakdown of academic impact, for papers by Laura Quotti Tubi Breakdown of academic impact, for papers by Susana Lisboa Breakdown of academic impact, for papers by Kerstin Maria Kampa-Schittenhelm Breakdown of academic impact, for papers by Mikara Robati Breakdown of academic impact, for papers by Christelle Vincent‐Fabert Breakdown of academic impact, for papers by Jean‐Loup Huret
Rankless by CCL
2026